WellNow is enrolling patients aged 40-80 years in a COPD study to determine the effectiveness a new medication to help manage the disease. Participants should have at least a 1-year diagnosis of COPD and have had at least 2 exacerbations in the past 12 months. This study runs 62 weeks with 29 study visits. Compensation is $3,200 over the course of this study.
Age 40-80 years
Diagnosed with COPD at least 12 months ago
Have had at least 2 exacerbations in the past 12 months
445 Balltown Road, Suite 1
Albany , New York 12304